Vial rack
Latest FATE THERAPEUTICS, INC. Patents:
- Cellular reprogramming using temporal and transient plasmid vector expression system
- Cells having solid tumor targeting backbone and use thereof
- Enhanced immune effector cells and use thereof
- Chimeric antigen receptor for tumor targeting
- Compositions and methods for immune cell modulation in adoptive immunotherapies
The dash lines, the areas within the dash lines, and the areas bounded by dash lines and solid lines depict portions of the vial rack that form no part of the claimed design. The dot-dash lines depict environmental subject matter and form no part of the claimed design.
Claims
The ornamental design for a vial rack, as shown and described.
4281768 | August 4, 1981 | Sommers |
4284603 | August 18, 1981 | Korom |
D265126 | June 22, 1982 | Beall |
4407958 | October 4, 1983 | DeGraff, Jr. |
D284700 | July 15, 1986 | Mehra |
5080232 | January 14, 1992 | Leoncavallo |
D392743 | March 24, 1998 | Stoufer |
6436351 | August 20, 2002 | Gubernator |
D677400 | March 5, 2013 | Blaettler |
D699859 | February 18, 2014 | Motadel |
D709718 | July 29, 2014 | Snyder |
D905272 | December 15, 2020 | Curry |
D921221 | June 1, 2021 | Sitton |
D930852 | September 14, 2021 | Rapier |
20060039834 | February 23, 2006 | Itoh |
20100089938 | April 15, 2010 | Motadel |
20100314051 | December 16, 2010 | Barger |
20150336102 | November 26, 2015 | Tyagi |
20160319329 | November 3, 2016 | Natale |
20200315349 | October 8, 2020 | Rapier |
- L2112 2 mL Vial Freezing Rack (Capacity 130 Vials). Online, published date unknown. Retrieved on Mar. 16, 2022 from URL: https://www.biolifesolutions.com/product/42812/.
Type: Grant
Filed: Apr 21, 2020
Date of Patent: Sep 5, 2023
Assignee: FATE THERAPEUTICS, INC. (San Diego, CA)
Inventor: Gabriel Rodriguez (San Diego, CA)
Primary Examiner: Omeed Agilee
Application Number: 29/732,115